Journal of the European Academy of Dermatology and Venereology : JEADV(2023)
引用4|浏览35
暂无评分
摘要
This study showed that most dupilumab-induced blepharoconjunctivitis cases are de novo. AD severity and conjunctivitis at baseline were not found to be associated risk factors in this study.